Dados B3 › BMOB3 × MLAS3
BMOB3 × MLAS3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BMOB3 | MLAS3 | year |
|---|---|---|---|
| ROE | 14.8% | 0.0% | 2025 |
| ROIC | 19.3% | 3.3% | 2025 |
| ROA | 9.2% | 2.3% | 2025 |
| Gross margin | 25.7% | 24.7% | 2025 |
| EBIT margin | 8.5% | 2.7% | 2025 |
| Net margin | 9.5% | 3.1% | 2025 |
| Net debt/EBITDA | -1.61x | -1.03x | 2025 |
| Current ratio | 1.86x | 1.92x | 2025 |
| Revenue growth (1y) | 13.2% | 15.8% | 2025 |
| Revenue growth (5y CAGR) | 58.1% | 6.6% | 2025 |
| Piotroski F-Score | 5/9 | 7/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BMOB3 | MLAS3 | year |
|---|---|---|---|
| P/E | 12.55x | — | 2025 |
| P/B | 2.06x | 0.37x | 2025 |
| EV/EBITDA | 7.62x | 5.71x | 2025 |
| FCF yield | 3.1% | 6.8% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 17:42 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 17:42 UTC. If this does not match /saude, you are reading a cached copy.